ACG, a global manufacturer for pharmaceutical and nutraceutical industries, has unveiled its patented Personalized Capsule Machine (PCM), a groundbreaking technology designed to produce custom-formulated supplement capsules tailored to individual specifications on demand.
Developed over five years, the PCM integrates real-time health data, precision dosing, and automated capsule production to create truly personalized nutritional supplements. This innovation represents a significant advancement in the growing field of personalized nutrition and precision medicine.
Strategic Partnership Drives Innovation
The technology was created through a strategic partnership between ACG and Art of You (AoY), combining ACG's expertise in capsule and beadlet technologies with AoY's specialization in formulations. This collaboration has resulted in a fully integrated system capable of delivering bespoke supplement solutions tailored to individual biomarkers, health goals, and lifestyle factors.
"After five years in development, we are thrilled to launch the PCM and collaborate with Art of You on this groundbreaking initiative. It represents a true leap forward in personalized nutrition," said Aaron Quinn, senior manager for Europe at Vantage Nutrition, part of the ACG group.
Advanced Technical Capabilities
According to ACG, the PCM technology offers several advanced features:
- Precision-engineered dosing for accurate formulation
- Clinically backed, science-driven formulations
- Personalized supplement accuracy
- Advanced bioavailability and absorption mechanisms
- Controlled-release coating technology
- Vegan, tasteless, and microplastic-free materials
- Pharmaceutical-grade, sustainable manufacturing processes
Pablo Smoulders, co-founder of Art of You, expressed enthusiasm about the collaboration: "By leveraging ACG's exceptional capsule technologies alongside our own expertise, we are bringing our vision of science-backed, personalized wellness closer to reality."
Market Impact and Future Plans
The commercial implications of this technology appear substantial. ACG has announced plans to deploy over 1,500 PCM machines across Europe in the next five years, with projected revenue exceeding €500 million over the next three years.
"This partnership underscores our commitment to growth through innovation and focus on advancing health solutions globally," Quinn added. "This initiative highlights ACG's leadership in delivering cutting-edge capsule and beadlet technologies to the market."
Comprehensive Delivery Solutions
In addition to the PCM, Vantage Nutrition will showcase its broader portfolio of advanced ingredient delivery technologies, including:
- Controlled release beadlets
- Liquid-filled hard capsules
- Cap-in-cap dosing solutions
These complementary technologies further enhance ACG's ability to provide comprehensive solutions for personalized nutrition and pharmaceutical applications.
Industry Showcase
The technology will be officially showcased at Vitafoods Europe 2025, taking place in Barcelona, Spain, during May 20-22, 2025. ACG, Art of You, and Vantage Nutrition will be exhibiting at Booth #3K6, where industry professionals can learn more about this innovative approach to personalized supplement formulation and production.
This development comes at a time when consumer demand for personalized health solutions continues to grow, potentially positioning ACG at the forefront of a significant shift in how nutritional supplements are formulated, produced, and delivered to consumers.
